Partnering with Leading Institutions

 

INTEGRATED CBD™ is in discussions with leading academic research institutions.

Press Releases Coming Soon. 

 

Our facilities are being designed to meet the highest level of FDA and USDA guidelines.
— Jeff Dreyer, Chief Operating Officer

CBD RESEARCH

IN THE PRESS

US National Library of Medicine: Cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

Proceedings of the National Academy of Sciences of the United States of America: Recent clinical trials of cannabidiol (CBD) in Dravet syndrome (DS) support its clinical efficacy for reduction of seizure frequency and invite study of its benefits for additional DS symptoms.

U.S. Food and Drug Administration: The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, 


WE ARE SEEKING MORE RESEARCH PARTNERS

If you need research funding or are interested in collaborating on CBD, INDUSTRIAL HEMP, OR SEED GENETICS research, contact us by filling out the form below.

 
Name *
Name
Choose what I am:
 

PROUD MEMBER